Eastman Chemical (NYSE:EMN) Holdings Cut by Czech National Bank

Czech National Bank lowered its holdings in Eastman Chemical (NYSE:EMNFree Report) by 0.6% during the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 20,637 shares of the basic materials company’s stock after selling 128 shares during the period. Czech National Bank’s holdings in Eastman Chemical were worth $2,068,000 at the end of the most recent quarter.

A number of other large investors have also recently bought and sold shares of the business. Mather Group LLC. bought a new position in Eastman Chemical in the first quarter worth about $125,000. Butensky & Cohen Financial Security Inc. raised its holdings in shares of Eastman Chemical by 1.5% during the first quarter. Butensky & Cohen Financial Security Inc. now owns 45,492 shares of the basic materials company’s stock valued at $4,559,000 after buying an additional 689 shares during the last quarter. CWM LLC raised its holdings in shares of Eastman Chemical by 8.4% during the first quarter. CWM LLC now owns 4,378 shares of the basic materials company’s stock valued at $439,000 after buying an additional 339 shares during the last quarter. Canandaigua National Bank & Trust Co. raised its holdings in shares of Eastman Chemical by 7.2% during the first quarter. Canandaigua National Bank & Trust Co. now owns 22,014 shares of the basic materials company’s stock valued at $2,206,000 after buying an additional 1,488 shares during the last quarter. Finally, Nomura Holdings Inc. bought a new stake in shares of Eastman Chemical during the fourth quarter valued at approximately $214,000. Institutional investors own 83.65% of the company’s stock.

Eastman Chemical Trading Up 0.5 %

NYSE EMN opened at $98.61 on Friday. Eastman Chemical has a twelve month low of $68.89 and a twelve month high of $105.98. The company has a debt-to-equity ratio of 0.77, a quick ratio of 0.71 and a current ratio of 1.39. The stock has a market cap of $11.60 billion, a price-to-earnings ratio of 12.71, a PEG ratio of 1.06 and a beta of 1.51. The firm’s 50 day moving average price is $99.11 and its two-hundred day moving average price is $92.79.

Eastman Chemical (NYSE:EMNGet Free Report) last issued its earnings results on Thursday, April 25th. The basic materials company reported $1.61 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.41 by $0.20. The company had revenue of $2.31 billion during the quarter, compared to analyst estimates of $2.29 billion. Eastman Chemical had a net margin of 10.16% and a return on equity of 13.84%. The company’s revenue for the quarter was down 4.2% on a year-over-year basis. During the same quarter last year, the business posted $1.63 EPS. Equities analysts anticipate that Eastman Chemical will post 7.75 EPS for the current year.

Eastman Chemical Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, July 9th. Investors of record on Monday, June 17th will be issued a $0.81 dividend. This represents a $3.24 dividend on an annualized basis and a yield of 3.29%. The ex-dividend date is Monday, June 17th. Eastman Chemical’s dividend payout ratio is presently 41.75%.

Insider Buying and Selling

In related news, SVP Adrian James Holt sold 1,975 shares of the company’s stock in a transaction on Monday, June 3rd. The shares were sold at an average price of $99.22, for a total value of $195,959.50. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. In related news, SVP Adrian James Holt sold 1,975 shares of the company’s stock in a transaction on Monday, June 3rd. The shares were sold at an average price of $99.22, for a total value of $195,959.50. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, CEO Mark J. Costa sold 102,390 shares of the company’s stock in a transaction on Tuesday, May 7th. The stock was sold at an average price of $100.78, for a total transaction of $10,318,864.20. Following the completion of the sale, the chief executive officer now owns 395,699 shares of the company’s stock, valued at $39,878,545.22. The disclosure for this sale can be found here. Over the last three months, insiders sold 108,027 shares of company stock worth $10,885,638. Corporate insiders own 1.93% of the company’s stock.

Analysts Set New Price Targets

A number of equities research analysts have recently weighed in on EMN shares. Wells Fargo & Company lifted their price target on Eastman Chemical from $89.00 to $100.00 and gave the company an “equal weight” rating in a report on Thursday, April 11th. Bank of America lowered their price objective on shares of Eastman Chemical from $113.00 to $112.00 and set a “buy” rating on the stock in a research note on Monday, April 29th. Royal Bank of Canada lifted their price target on shares of Eastman Chemical from $100.00 to $104.00 and gave the stock a “sector perform” rating in a research report on Tuesday, April 30th. Barclays lifted their price target on shares of Eastman Chemical from $85.00 to $103.00 and gave the stock an “equal weight” rating in a research report on Monday, May 6th. Finally, StockNews.com lowered shares of Eastman Chemical from a “buy” rating to a “hold” rating in a research report on Thursday. Seven equities research analysts have rated the stock with a hold rating and ten have assigned a buy rating to the company’s stock. Based on data from MarketBeat, Eastman Chemical presently has a consensus rating of “Moderate Buy” and a consensus target price of $107.50.

Check Out Our Latest Report on Eastman Chemical

Eastman Chemical Profile

(Free Report)

Eastman Chemical Company operates as a specialty materials company in the United States, China, and internationally. The company's Additives & Functional Products segment offers amine derivative-based building blocks, intermediates for surfactants, metam-based soil fumigants, and organic acid-based solutions; specialty coalescent and solvents, paint additives, and specialty polymers; and heat transfer and aviation fluids.

Featured Stories

Want to see what other hedge funds are holding EMN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Eastman Chemical (NYSE:EMNFree Report).

Institutional Ownership by Quarter for Eastman Chemical (NYSE:EMN)

Receive News & Ratings for Eastman Chemical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Eastman Chemical and related companies with MarketBeat.com's FREE daily email newsletter.